Tolerance of paclitaxel 3-hour infusion with and without granulocyte colony-stimulating factor on a biweekly schedule

Seminars in Oncology

Volumn 24, Issue 6 SUPPL. 19, 1997, Pages

  Garcia, A A ^a   Parimoo, D ^a   Dimery, I ^a   Rogers, M ^a   Jeffers, S ^a   Muggia, F M ^a  

^a Kaplan Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL;

ADULT; ARTHRALGIA; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DOSE RESPONSE; DRUG TOLERANCE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; MALE; METASTASIS; MYALGIA; NAUSEA; NEUROPATHY; NEUROTOXICITY; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENT CANCER; STOMATITIS; SUBCUTANEOUS DRUG ADMINISTRATION; VOMITING;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEUTROPENIA; PACLITAXEL; TREATMENT OUTCOME;

EID: 17944397622     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)